Lilly will acquire Curevo in a deal worth up to $1.5 billion in cash, including upfront and milestone-based payments.
The new facility marks Align’s first manufacturing presence in India and its fourth globally
AAV vectors are widely used in gene therapy for their strong therapeutic potential
If approved, TEV-‘749 would mark a shift toward long-acting care aimed at improving treatment adherence in real-world settings
No approved vaccine or specific treatment currently available for Bundibugyo strain Ebola disease
Revenue from operations climbed 13% to Rs. 886.87 crore
Expands Davaindia network to 2,579 stores
The decision marks a key step in the centralized EU review process
The company said the breadth of its showcase reflects “progress from its differentiated oncology pipeline in solid tumors and hematologic malignancies,”
With standout ADC and t-cell engager response data across hard-to-treat cancers
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
